Pharmacologic Treatment of Depression
Heather Kovich1, William Kim2, Anthony M Quaste3
1Shiprock-University of New Mexico Family Medicine Residency Program and Northern Navajo Medical Center, Shiprock, New Mexico.
American Family Physician
|February 15, 2023
Summary
Antidepressant use has increased significantly, with second-generation medications and psychotherapy being first-line depression treatments. Discontinuing antidepressants raises relapse risk, but gradual tapering with therapy can mitigate this.
Area of Science:
- Clinical Psychology
- Psychiatry
- Pharmacology
Background:
- The United States has seen a steady rise in depression prevalence and antidepressant prescriptions over the last 30 years.
- Antidepressants are the most frequently prescribed medications for adults aged 20-59 in the U.S.
- Second-generation antidepressants (SSRIs, SNRIs, etc.) and psychotherapy (like CBT) are primary treatments for depression.
Purpose of the Study:
- To review the current landscape of depression treatment, focusing on antidepressant medications and psychotherapy.
- To highlight considerations for selecting antidepressant therapy, including patient history and risks.
- To examine the long-term safety and effectiveness of antidepressants and the implications of discontinuation.
Main Methods:
- Literature review and synthesis of existing research on antidepressant use, efficacy, and safety.
- Analysis of treatment guidelines for depression, including first-line and combination therapies.
- Examination of studies investigating antidepressant discontinuation and relapse rates.
Main Results:
- Second-generation antidepressants and psychotherapy are established first-line treatments; combination therapy is preferred for severe depression.
- Factors such as treatment history, comorbidities, cost, and adverse effects influence medication choice.
- Discontinuing antidepressants increases the risk of relapse, which can be reduced by gradual tapering and concurrent psychotherapy.
- Limited high-quality data exists on antidepressant use during pregnancy, though both depression and medication use are linked to preterm birth.
Conclusions:
- Antidepressant therapy and psychotherapy are crucial for managing depression, with careful consideration of individual patient factors.
- Long-term antidepressant use requires further research regarding safety and effectiveness.
- Strategies like gradual tapering combined with cognitive behavior therapy can help manage the risks associated with discontinuing antidepressants.
More Related Videos
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
291
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
291
01:25Antidepressant Drugs: Overview
659
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
659
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
492
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
492
01:28Drug Therapy
82
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
82
01:26Psychosis: Goals of Pharmacotherapy
181
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
181
01:22Alzheimer's Disease: Treatment
235
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
235